Clinical Trial Update: QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for QUILT-2.015 evaluating AMG 479 in combination with exemestane or fulvestrant in postmenopausal women with hormone receptor-pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• AMG 479
• Exemestane (Exemestane)
• Fulvestrant (fulvestrant)

Snippet

Sponsor: NantCell, Inc. | Conditions: Breast Cancer, Breast Tumors | Phase 2 | Status: COMPLETED | Results posted: 2024-09-19